Proteome Sciences plc (LON:PRM – Get Free Report)’s share price traded up 9% on Monday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). 967,070 shares were traded during mid-day trading, an increase of 496% from the average session volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Up 3.5 %
The business has a 50-day moving average of GBX 2.73 and a 200-day moving average of GBX 3.15. The stock has a market cap of £9.65 million, a price-to-earnings ratio of -327.00 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- 3 Stocks to Consider Buying in October
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Differences Between Momentum Investing and Long Term Investing
- 2 Drone Stocks Surging from Increased Media Attention
- What is a Low P/E Ratio and What Does it Tell Investors?
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
